IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIA S AGORRILLA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1659775708
CMS profile
10947247
Location
TEMECULA, CA

General Payments · PY2021–2024

$3,054.06

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,143.87

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,143.87 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $356.52 12
Novo Nordisk AS $224.15 9
Bayer HealthCare Pharmaceuticals Inc. $218.64 12
Salix Pharmaceuticals, a division of Bausch Health US, LLC $132.06 9
EISAI INC. $105.51 1
Exact Sciences Corporation $57.58 3
Boehringer Ingelheim Pharmaceuticals, Inc. $34.74 2
Lilly USA, LLC $14.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $927.18 40
PY2022 $567.64 21
PY2023 $415.37 26
PY2024 $1,143.87 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $38.81 01/30/2024 Food and Beverage Undisputed 01/23/2026 1104681149 CMS
AstraZeneca Pharmaceuticals LP $18.22 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104556556 CMS
AstraZeneca Pharmaceuticals LP $16.97 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105760363 CMS
AstraZeneca Pharmaceuticals LP $13.52 04/08/2024 Food and Beverage Undisputed 01/23/2026 1105490837 CMS
AstraZeneca Pharmaceuticals LP $17.75 04/15/2024 Food and Beverage Undisputed 01/23/2026 1105478571 CMS
AstraZeneca Pharmaceuticals LP $19.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104552546 CMS
AstraZeneca Pharmaceuticals LP $24.86 06/10/2024 Food and Beverage Undisputed 01/23/2026 1104730187 CMS
AstraZeneca Pharmaceuticals LP $23.25 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105659394 CMS
AstraZeneca Pharmaceuticals LP $20.26 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105587022 CMS
AstraZeneca Pharmaceuticals LP $124.99 10/30/2024 Food and Beverage Undisputed 01/23/2026 1105293045 CMS
AstraZeneca Pharmaceuticals LP $17.34 12/04/2024 Food and Beverage Undisputed 01/23/2026 1104776658 CMS
AstraZeneca Pharmaceuticals LP $20.92 12/18/2024 Food and Beverage Undisputed 01/23/2026 1104393243 CMS
Bayer Healthcare Pharmaceuticals Inc. $9.78 05/20/2024 Food and Beverage Undisputed 01/23/2026 1086106198 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086333291 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.50 07/31/2024 Food and Beverage Undisputed 01/23/2026 1086332831 CMS
Bayer Healthcare Pharmaceuticals Inc. $42.12 08/06/2024 Food and Beverage Undisputed 01/23/2026 1086307915 CMS
Bayer Healthcare Pharmaceuticals Inc. $6.67 08/12/2024 Food and Beverage Undisputed 01/23/2026 1086104794 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.10 08/27/2024 Food and Beverage Undisputed 01/23/2026 1086350955 CMS
Bayer Healthcare Pharmaceuticals Inc. $6.11 09/04/2024 Food and Beverage Undisputed 01/23/2026 1086101373 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.09 10/01/2024 Food and Beverage Undisputed 01/23/2026 1086370653 CMS
Bayer Healthcare Pharmaceuticals Inc. $30.01 10/03/2024 Food and Beverage Undisputed 01/23/2026 1086303933 CMS
Bayer Healthcare Pharmaceuticals Inc. $11.80 10/29/2024 Food and Beverage Undisputed 01/23/2026 1086100737 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.67 11/05/2024 Food and Beverage Undisputed 01/23/2026 1086105352 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.59 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086357872 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.16 02/26/2024 Food and Beverage Undisputed 01/23/2026 1118100558 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.58 05/20/2024 Food and Beverage Undisputed 01/23/2026 1118100560 CMS
Eisai Inc. $105.51 12/10/2024 Food and Beverage Undisputed 01/23/2026 1110813426 CMS
Exact Sciences Corporation $15.41 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114552654 CMS
Exact Sciences Corporation $22.50 04/17/2024 Food and Beverage Undisputed 01/23/2026 1114552658 CMS
Exact Sciences Corporation $19.67 10/02/2024 Food and Beverage Undisputed 01/23/2026 1114552662 CMS
Lilly USA, LLC $14.67 06/07/2024 Food and Beverage Undisputed 01/23/2026 1135775068 CMS
Novo Nordisk Inc $17.79 03/19/2024 Food and Beverage Undisputed 01/23/2026 1100574612 CMS
Novo Nordisk Inc $7.13 04/15/2024 Food and Beverage Undisputed 01/23/2026 1100631879 CMS
Novo Nordisk Inc $14.56 08/26/2024 Food and Beverage Undisputed 01/23/2026 1100454592 CMS
Novo Nordisk Inc $12.21 09/10/2024 Food and Beverage Undisputed 01/23/2026 1100430129 CMS
Novo Nordisk Inc $30.26 09/24/2024 Food and Beverage Undisputed 01/23/2026 1100488817 CMS
Novo Nordisk Inc $11.01 10/01/2024 Food and Beverage Undisputed 01/23/2026 1100649291 CMS
Novo Nordisk Inc $113.57 10/22/2024 Food and Beverage Undisputed 01/23/2026 1100441429 CMS
Novo Nordisk Inc $4.20 10/31/2024 Food and Beverage Undisputed 01/23/2026 1100374607 CMS
Novo Nordisk Inc $13.42 12/05/2024 Food and Beverage Undisputed 01/23/2026 1100605420 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.88 03/08/2024 Food and Beverage Undisputed 01/23/2026 1153667442 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $5.85 04/24/2024 Food and Beverage Undisputed 01/23/2026 1153662176 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.70 05/14/2024 Food and Beverage Undisputed 01/23/2026 1153638580 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.82 07/10/2024 Food and Beverage Undisputed 01/23/2026 1153760915 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.93 07/25/2024 Food and Beverage Undisputed 01/23/2026 1153492673 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.94 09/10/2024 Food and Beverage Undisputed 01/23/2026 1153482120 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $5.99 10/15/2024 Food and Beverage Undisputed 01/23/2026 1153499453 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.38 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153481650 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.57 12/30/2024 Food and Beverage Undisputed 01/23/2026 1153467665 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.